These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20629849)

  • 1. High prevalence and risk factors of thromboembolism in stage IV melanoma.
    Sparsa A; Durox H; Doffoel-Hantz V; Munyangango EM; Bédane C; Cendras J; Gantois C; Boulinguez S; Bonnetblanc JM
    J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):340-4. PubMed ID: 20629849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and risk factors of venous thromboembolic events in lymphoma.
    Zhou X; Teegala S; Huen A; Ji Y; Fayad L; Hagemeister FB; Gladish G; Vadhan-Raj S
    Am J Med; 2010 Oct; 123(10):935-41. PubMed ID: 20920696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications of intravenous heparin therapy for treatment of thromboembolic disease in joint arthroplasty patients.
    Pence CD; Spencer S
    Kans Med; 1996; 97(1):16-8. PubMed ID: 8676585
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative management of epistaxis: are we putting patients at risk of developing venous thromboembolic complications?
    Karagama YG; Anari S; Lancaster JL; Karkanevatos A; Jones TM; Sherman IW
    Rhinology; 2005 Jun; 43(2):135-7. PubMed ID: 16008070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in 5 Gulf countries.
    Al Sayegh F; Almahmeed W; Al Humood S; Marashi M; Bahr A; Al Mahdi H; Bakir S; Al Farhan M
    Clin Appl Thromb Hemost; 2009; 15(3):289-96. PubMed ID: 18400764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of thromboembolism after transurethral resection of the prostate (TURP)--a study on TED stocking prophylaxis and literature review.
    Donat R; Mancey-Jones B
    Scand J Urol Nephrol; 2002; 36(2):119-23. PubMed ID: 12028685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Travel-related thrombosis: is this a problem?
    Brenner B
    Isr Med Assoc J; 2006 Dec; 8(12):859-61. PubMed ID: 17216870
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of major bleeding in unselected patients with venous thromboembolism.
    Bigaroni A; Perrier A; de Moerloose P; Perneger T; Bounameaux H
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):199-202. PubMed ID: 10759014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence and prevention of venous thromboembolic events in general practice. Multicenter, prospective cohort study].
    Pouchain D; Bergmann JF; Bosson JL
    Rev Prat; 2008 Dec; 58(19 Suppl):3-8. PubMed ID: 19253785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboembolism in children with sarcoma.
    Athale U; Cox S; Siciliano S; Chan AK
    Pediatr Blood Cancer; 2007 Aug; 49(2):171-6. PubMed ID: 16991135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboembolism and venous thrombosis of the deep veins in surgical children--an increasing challenge?
    Tshifularo N; Arnold M; Moore SW
    J Pediatr Surg; 2011 Mar; 46(3):433-6. PubMed ID: 21376188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of patients hospitalized with venous thromboembolism: comparison between cancer and non-cancer patients.
    Kolomansky A; Hoffman R; Sarig G; Brenner B; Haim N
    Isr Med Assoc J; 2006 Dec; 8(12):848-52. PubMed ID: 17214102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rationalization of risk factors for venous thromboembolism in medical inpatients. A prospective study].
    Pottier P; Planchon B; Truchaud F; Pistorius MA; Furic I; Grolleau JY
    J Mal Vasc; 2000 Oct; 25(4):241-9. PubMed ID: 11060418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial and gender differences in the incidence of recurrent venous thromboembolism.
    White RH; Dager WE; Zhou H; Murin S
    Thromb Haemost; 2006 Sep; 96(3):267-73. PubMed ID: 16953266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboembolic events during continuous vasopressin infusions: a retrospective evaluation.
    Doepker BA; Lucarelli MR; Lehman A; Shirk MB
    Ann Pharmacother; 2007 Sep; 41(9):1383-9. PubMed ID: 17684034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism in medical patients--the scope of the problem.
    Haas S
    Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():17-21. PubMed ID: 14730474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboembolic diseases.
    Wakefield TW; Caprini J; Comerota AJ
    Curr Probl Surg; 2008 Dec; 45(12):844-99. PubMed ID: 18984095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.